These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11660141)

  • 1. Regulation of drug treatments for HIV and AIDS: a contractarian model of access.
    Salbu SR
    Yale J Regul; 1994; 11(2):401-53. PubMed ID: 11660141
    [No Abstract]   [Full Text] [Related]  

  • 2. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials.
    Annas GJ
    Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS and the FDA: an ethical case for limiting patient access to new medical therapies.
    Shorr AF
    IRB; 1992; 14(4):1-5. PubMed ID: 11651391
    [No Abstract]   [Full Text] [Related]  

  • 4. Getting new drugs to people with AIDS: a public policy response to Lansdale.
    Cohen MN
    Hastings Constit Law Q; 1991; 18(3):471-85. PubMed ID: 11651493
    [No Abstract]   [Full Text] [Related]  

  • 5. The need for improved access to experimental drug therapy: AIDS activists and their call for a parallel track policy.
    Terrizzi L
    Adm Law J; 1991; 4(3):589-634. PubMed ID: 11659598
    [No Abstract]   [Full Text] [Related]  

  • 6. Making experimental drugs available for AIDS treatment.
    Krim M
    AIDS Public Policy J; 1987; 2(2):1-5. PubMed ID: 11650026
    [No Abstract]   [Full Text] [Related]  

  • 7. Private rights to adulterated/misbranded articles.
    McMonagle L
    AIDS Public Policy J; 1987; 2(2):33-49. PubMed ID: 11650029
    [No Abstract]   [Full Text] [Related]  

  • 8. Informed consent and the HIV-positive physician.
    Lunde JK
    Med Trial Tech Q; 1992; 38():186-204. PubMed ID: 11653087
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatments of last resort: informed consent and the diffusion of new technology.
    King NM; Henderson G
    Mercer Law Rev; 1991; 42(3):1007-50. PubMed ID: 11651433
    [No Abstract]   [Full Text] [Related]  

  • 10. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
    Dunbar MM
    Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
    [No Abstract]   [Full Text] [Related]  

  • 11. The right of privacy in choosing medical treatment: should terminally ill persons have access to drugs not yet approved by the Food and Drug Administration?
    Power SH
    John Marshall Law Rev; 1987; 20(4):693-714. PubMed ID: 11650094
    [No Abstract]   [Full Text] [Related]  

  • 12. The changing clinical trials scene: the role of the IRB.
    Mitchell SC; Steingrub J
    IRB; 1988; 10(4):1-5. PubMed ID: 11650078
    [No Abstract]   [Full Text] [Related]  

  • 13. Considering experimentation and elusive truth: informed consent made difficult.
    Brodeur D
    Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
    [No Abstract]   [Full Text] [Related]  

  • 14. If a subject incurs obligations and carries them out, then consent is a contract: Dahl v. HEM Pharmaceuticals (Part II).
    Maloney DM
    Hum Res Rep; 1996 Jan; 11(1):4-5. PubMed ID: 11653221
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA's new rule on treatment use and sale of investigational new drugs.
    Levine RJ
    IRB; 1987; 9(4):1-4. PubMed ID: 11649946
    [No Abstract]   [Full Text] [Related]  

  • 16. Despite "clinical hold," subjects have right to keep getting experimental drug: Dahl v. HEM Pharmaceuticals Corporation (Part III).
    Maloney DM
    Hum Res Rep; 1996 Feb; 11(2):4-5. PubMed ID: 11654437
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethical perspectives on the FDA and ADA evaluation of dental products.
    Veatch RM
    J Public Health Dent; 1992; 52(6; Spec. Iss):387-90. PubMed ID: 11659654
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of legal controls on human experimentation and the regulatory implications of taking Professor Katz seriously.
    Goldner JA
    St Louis Univ Law J; 1993; 38(1):63-134. PubMed ID: 11656325
    [No Abstract]   [Full Text] [Related]  

  • 19. New rules for new drugs: the challenge of AIDS to the regulatory process.
    Edgar H; Rothman DJ
    Milbank Q; 1990; 68(Suppl. 1):111-42. PubMed ID: 11650413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS treatment drugs: clinical trials and compassionate use.
    Levine RJ
    AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.